https://www.prnewswire.com/news-releases/nls-pharmaceutics-and-kadimastem-unveil-multi-target-approach-to-diabetes-expanding-beyond-glp-1-therapies-302372224.html
NLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1...
/PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of...